Citadel Advisors
PRPH

Citadel Advisors’s ProPhase Labs PRPH Stock Holding History

Citadel Advisors’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,230
Closed -$4.81K – 13808
2025
Q2 		$4.81K Buy
+1,230
New +$4.11K ﹤0.01% 12236
2024
Q3 		– Sell
-50
Closed -$2.09K – 15008
2024
Q2 		$2.09K Sell
50
-190
-79% -$9.96K ﹤0.01% 13736
2024
Q1 		$15.5K Buy
+240
New +$12.2K ﹤0.01% 13183
2023
Q4 		– Sell
-1,170
Closed -$51.1K – 15020
2023
Q3 		$51.1K Sell
1,170
-260
-18% -$15.2K ﹤0.01% 11738
2023
Q2 		$104K Buy
1,430
+580
+68% +$47.2K ﹤0.01% 10876
2023
Q1 		$64.8K Sell
850
-20
-2% -$1.61K ﹤0.01% 11825
2022
Q4 		$83.8K Buy
+870
New +$94K ﹤0.01% 11458
2022
Q3 		– Sell
-1,690
Closed -$214K – 13381
2022
Q2 		$214K Buy
+1,690
New +$149K ﹤0.01% 10562
2021
Q3 		– Sell
-2,030
Closed -$126K – 14464
2021
Q2 		$126K Buy
2,030
+900
+80% +$50.5K ﹤0.01% 12696
2021
Q1 		$84K Buy
+1,130
New +$108K ﹤0.01% 12608

Other funds holding PRPH

SC
Sykon Capital Harrison, New York $300M AUM 16.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $412M AUM 15.82% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors's PRPH Position: Q3 2024 in Review

Citadel Advisors sold out of ProPhase Labs (PRPH) in Q3 2024, closing a stake of 380 shares — an estimated $15.9K sold.

Citadel Advisors first reported a position in PRPH in Q4 2013 and held it in 20 quarters. The position peaked at $204K in Q4 2021. 27 funds tracked by Wall St. Rank hold PRPH as of Q3 2024.

  • Citadel Advisors reported no remaining ProPhase Labs position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 380 ProPhase Labs shares in Q3 2024, an estimated $15.9K.
  • Citadel Advisors first reported a position in ProPhase Labs in Q4 2013 and held it in 20 quarters.
  • Citadel Advisors's ProPhase Labs position peaked at $204K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.